Before taking Dacomitinib(Vizimpro)

Patients should avoid proton pump inhibitors and use caution with CYP2D6 substrates while on VIZIMPRO.

Important Safety Information

VIZIMPRO can cause fetal harm, so effective contraception is advised for females of reproductive potential. It is also not recommended during breastfeeding. Concomitant use with proton pump inhibitors should be avoided due to reduced efficacy. Additionally, caution is needed when taking other drugs that are CYP2D6 substrates.